ANDA 89497, held by Par Pharm. Imipramine Hydrochloride.
As of Nov 16, 2026, ANDA 89497 (Imipramine Hydrochloride), held by Par Pharm, was first approved by FDA on Jul 14, 1987, with 10 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 14, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Imipramine Hydrochloride25MG · tablet;oral | Imipramine Hydrochloride | Discontinued |
| Oct 2, 1997 | Supplement 12Manufacturing | Approved | None posted |
| Mar 25, 1996 | Supplement 9Labeling | Approved | None posted |
| Mar 25, 1996 | Supplement 10Manufacturing | Approved | None posted |
| Mar 25, 1996 | Supplement 11Manufacturing | Approved | None posted |
| Oct 23, 1995 | Supplement 8Labeling | Approved | None posted |
| Nov 5, 1993 | Supplement 7Labeling | Approved | None posted |
| Jan 7, 1991 | Supplement 6Labeling | Approved | None posted |
| Aug 19, 1988 | Supplement 1Manufacturing | Approved | None posted |
| Aug 19, 1988 | Supplement 3Manufacturing | Approved | None posted |
| Aug 19, 1988 | Supplement 4Manufacturing | Approved | None posted |
| Jul 14, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters